Company · CIK 1809122
CureVac N.V.
| CIK | 1809122 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-04-27 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-252391 | 2021-01-25 | 2021-01-29 | 3 | |
| 333-240076 | 2020-07-24 | 2020-08-14 | 6 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-02-09 | 424B5Shelf takedown | 333-259613 | 0001104659-23-017551 |
| 2023-02-06 | 424B4Final prospectus | 333-259613 | 0001104659-23-011269 |
| 2021-01-29 | 424B4Final prospectus | 333-252391 | 0001104659-21-009416 |
| 2021-01-27 | EFFECTDeclared effective | 333-252391 | 9999999995-21-000314 |
| 2021-01-25 | F-1Registration filed | 333-252391 | 0001104659-21-007168 |
| 2020-11-27 | DRSDraft made public | 377-03838 | 0001104659-20-130083 |
| 2020-08-14 | 424B4Final prospectus | 333-240076 | 0001104659-20-095636 |
| 2020-08-13 | EFFECTDeclared effective | 333-240076 | 9999999995-20-002135 |
| 2020-08-10 | F-1/AAmendment | 333-240076 | 0001104659-20-092289 |
| 2020-08-07 | F-1/AAmendment | 333-240076 | 0001104659-20-091817 |
| 2020-07-31 | F-1/AAmendment | 333-240076 | 0001104659-20-089179 |
| 2020-07-24 | F-1Registration filed | 333-240076 | 0001104659-20-086354 |
| 2020-04-29 | DRSDraft made public | 377-03144 | 0001104659-20-053520 |